FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4669011000001106: Co-flumactone 50mg/50mg tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21269701000001115 Co-flumactone 50mg/50mg tablets 28 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21269801000001112 Co-flumactone 50mg/50mg tablets 28 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-flumactone 50mg/50mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Is pack of Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has active ingredient Hydroflumethiazide false Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has VMP Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has specific active ingredient Hydroflumethiazide true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Co-flumactone 50mg/50mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aldactide 50 tablets (Pfizer Ltd) 28 tablet 2 x 14 tablets Is a True Co-flumactone 50mg/50mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start